Impact of the "Zero Resistance" program on acquisition of multidrug-resistant bacteria in patients admitted to Intensive Care Units in Spain. A prospective, intervention, multimodal, multicenter study.
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Álvarez-Lerma F
- Catalán-González M
- Álvarez J
- Sánchez-García M
- Palomar-Martínez M
- Fernández-Moreno I
- Garnacho-Montero J
- Barcenilla-Gaite F
- García R
- Aranaz-Andrés J
- Lozano-García FJ
- Martínez-Alonso M
Grupos
Abstract
OBJECTIVE: To assess the impact of a multimodal interventional project ("Zero Resistance") on the acquisition of multidrug-resistant bacteria (MDR-B) during the patient's ICU stay. DESIGN: Prospective, open-label, interventional, multicenter study. SETTING: 103 ICUs. PATIENTS: Critically ill patients admitted to the ICUs over a 27-month period. INTERVENTIONS: Implementation of a bundle of 10 recommendations to prevent emergence and spread of MDR-B in the ICU. MAIN VARIABLE OF INTEREST: Rate of patients acquiring MDR-B during their ICU stay, with differentiation between colonization and infection. RESULTS: A total of 139,505 patients were included. In 5409 (3.9%) patients, 6020 MDR-B on ICU admission were identified, and in 3648 (2.6%) patients, 4269 new MDR-B during ICU stay were isolated. The rate of patients with MDR-B detected on admission increased significantly (IRR 1.43, 95% CI 1.31-1.56) (p<0.001) during the study period, with an increase of 32.2% between the initial and final monthly rates. On the contrary, the rate of patients with MDR-B during ICU stay decreased non-significantly (IRR 0.93, 95% CI 0.83-1.03) (p=0.174), with a 24.9% decrease between initial and final monthly rates. According to the classification into colonization or infection, there was a highly significant increase of MDR-B colonizations detected on admission (IRR 1.69, 95% CI 1.52-1.83; p<0.0001) and a very significant decrease of MDR-B-infections during ICU stay (IRR 0.67, 95% CI 0.57-0.80, p<0.0001). CONCLUSIONS: The implementation of ZR project-recommendations was associated with a significantly reduction an infection produced by MDR-B acquired during the patient's ICU stay.
Copyright © 2022. Published by Elsevier España, S.L.U.
Datos de la publicación
- ISSN/ISSNe:
- 2173-5727, 2173-5727
- Tipo:
- Article
- Páginas:
- 193-202
- PubMed:
- 36670011
Medicina intensiva
Citas Recibidas en Web of Science: 11
Documentos
- No hay documentos
Filiaciones
Keywords
- Aislamiento preventivo; Antimicrobial use; BMR; Critical ill patient; Eliminación de reservorios; Elimination of reservoirs; Estudios de vigilancia; ICU; Multidrug-resistant bacteria; Paciente crítico; Preventive isolation; Surveillance studies; Uso antimicrobianos; “Proyecto Resistencia Zero”; “Zero Resistance Project”
Cita
Álvarez F,Catalán M,Álvarez J,Sánchez M,Palomar M,Fernández I,Garnacho J,Barcenilla F,García R,Aranaz J,Lozano FJ,RAMÍREZ P,Martínez M. Impact of the "Zero Resistance" program on acquisition of multidrug-resistant bacteria in patients admitted to Intensive Care Units in Spain. A prospective, intervention, multimodal, multicenter study. Med Intensiva (Engl Ed). 2023. 47. (4):p. 193-202.
Portal de investigación